Which medication combination is contained in Yosprala?

Yosprala is specifically formulated to combine aspirin and omeprazole. This combination aims to provide both cardioprotective effects of aspirin and the gastrointestinal protection offered by omeprazole, a proton pump inhibitor. The inclusion of omeprazole helps to prevent the gastric ulcers and erosions that can be a side effect of long-term aspirin use, making Yosprala particularly useful for patients at risk of gastrointestinal complications while they are on aspirin therapy.

The other combinations listed do not reflect the formulation of Yosprala. For example, while aspirin is often paired with clopidogrel or dipyridamole in various cardiovascular treatments, those combinations are not part of Yosprala. Aspirin and atorvastatin represent another type of therapy but do not involve the gastrointestinal protective aspect that omeprazole provides. Thus, the correct pairing in Yosprala is indeed aspirin and omeprazole, making this combination uniquely beneficial for specific patient needs.